Showing results (201-210 of 213) with videos related to
Sort By:
Pageof 22
Journal of Cachexia, Sarcopenia and Muscle|February 26, 2020
Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatmentEliza R C Hagens, Minke L Feenstra, Maarten A van Egmond, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2014
Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenariosMartine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, et al.Nederlands Tijdschrift Voor Geneeskunde|November 14, 2013
[Societal costs of asthma, COPD and respiratory allergy]Anita W M Suijkerbuijk, G A Ardine de Wit, Alet H Wijga, et al.Diabetologia|April 5, 2020
Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care settingAmber A van der Heijden, Giel Nijpels, Fariza Badloe, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 17, 2001
Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjectsJ G Slatter, D J Stalker, K L Feenstra, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine?Martine Hoogendoorn, Talitha L Feenstra, Yumi Asukai, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 30, 2026
Surgical Quality Assessment of paravertebral catheter placement in minimally invasive esophagectomy: an exploratory post hoc analysis of the PEPMEN- trialD C van der Aa, M D Teeken, C D Kooij, et al.BMJ (Clinical Research Ed.)|September 29, 2021
Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation studyRoderick C Slieker, Amber A W A van der Heijden, Moneeza K Siddiqui, et al.Plos One|May 11, 2019
A social cost-benefit analysis of two One Health interventions to prevent toxoplasmosisAnita W M Suijkerbuijk, Eelco A B Over, Marieke Opsteegh, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2000
Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patientsJ G Slatter, L J Schaaf, J P Sams, et al.Pageof 22